Clinical audit: virological and immunological response to combination antiretroviral therapy in HIV patients at a Sydney sexual health clinic

被引:1
|
作者
Hsu, D. C. [1 ]
Quin, J. W. [2 ,3 ]
机构
[1] Royal Prince Alfred Hosp, Dept Immunol, Sydney SW Area Hlth Serv, Camperdown, NSW 2050, Australia
[2] Liverpool Hlth Serv, Div Med, Sydney, NSW, Australia
[3] Univ New S Wales, Sydney, NSW, Australia
关键词
response to antiretroviral therapy; clinical audit; HIV virological control; HIV immunological response; PROTEASE INHIBITOR THERAPY; CELL COUNT; HIV-1-INFECTED PATIENTS; INFECTED PATIENTS; RANDOMIZED-TRIAL; PREDICTORS; FAILURE; INITIATION; INCREASES; ADHERENCE;
D O I
10.1111/j.1445-5994.2009.01983.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim: Bigge Park Centre (BPC) is a sexual health clinic located in a socially disadvantaged area in Southwest Sydney. This served as a retrospective clinical audit, documenting patient demographics, identifying factors associated with virological, immunological and discordant responses, evaluating the centre's ability in HIV control and investigating changes in practice from 1996 to 2007. Method: Data including age, gender, ethnicity, mode of transmission, hepatitis co-infection, prior acquired immune deficiency syndrome (AIDS)-defining-illness, HIV-1 RNA and CD4+cell counts of patients on combination antiretroviral therapy (CART) for treatment of HIV with at least 1-year follow up at the BPC were analysed. Results were compared with other cohorts in medical literature. Results: BPC manages HIV patients from diverse backgrounds. Sequential monotherapy was associated with poor virological control, lower CD4+cell recovery and discordant response. When patients who had sequential monotherapy were excluded, Caucasian race, high viral load at 1 month and triple-NRTI (nucleoside reverse transcriptase inhibitor) regimen were associated with lack of virological control. Lower baseline viral load and triple-NRTI regimen were associated with lower CD4+cell recovery. Lower baseline CD4+cell count and prior diagnosis of AIDS were associated with discordant response. Virological control and CD4+cell recovery achieved were comparable to that documented in medical literature. There was no significant change over time in terms of timing of CART initiation, attainment of immunological response or virological control since the late 1990s. Conclusion: HIV control achieved at the BPC was comparable to that reported in medical literature. Enhancement of strategies to promote screening and improve adherence as well as performance of HIV resistance assessment and avoidance of triple-NRTI therapy will likely improve patient care.
引用
收藏
页码:265 / 274
页数:10
相关论文
共 50 条
  • [41] Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study
    Wittkop, Linda
    Guenthard, Huldrych F.
    de Wolf, Frank
    Dunn, David
    Cozzi-Lepri, Alessandro
    de Luca, Andrea
    Kuecherer, Claudia
    Obel, Niels
    von Wyl, Viktor
    Masquelier, Bernard
    Stephan, Christoph
    Torti, Carlo
    Antinori, Andrea
    Garcia, Federico
    Judd, Ali
    Porter, Kholoud
    Thiebaut, Rodolphe
    Castro, Hannah
    van Sighem, Ard I.
    Colin, Celine
    Kjaer, Jesper
    Lundgren, Jens D.
    Paredes, Roger
    Pozniak, Anton
    Clotet, Bonaventura
    Phillips, Andrew
    Pillay, Deenan
    Chene, Genevieve
    LANCET INFECTIOUS DISEASES, 2011, 11 (05): : 363 - 371
  • [42] Oral health in Australian HIV patients since the advent of combination antiretroviral therapy
    不详
    AUSTRALIAN DENTAL JOURNAL, 2012, 57 (04) : 518 - 518
  • [43] A clinical rule for the prediction of meningitis in HIV patients in the era of combination antiretroviral therapy
    Abd El-Wahab, Ekram W.
    Farrag, Talaat
    Metwally, Mohammed
    TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2020, 114 (04) : 264 - 275
  • [44] Virological failure and adherence to antiretroviral therapy in HIV-infected patients
    Rodríguez-Rosado, R
    Jiménez-Nácher, I
    Soriano, V
    Antón, P
    González-Lahoz, A
    AIDS, 1998, 12 (09) : 1112 - 1113
  • [45] Immunological, virological and clinical response in patients infected with HIV after highly active antiviral therapy with nelfinavir:: prospective cohort study
    de Alarcón, A
    Viciana, P
    Lozano, F
    Vergara, A
    Pujol, E
    Barrera, A
    Pérez-Guzmán, E
    Colmenero, MA
    Hernández-Quero, J
    Márquez, M
    de la Torre, J
    Aliaga, L
    Suárez, I
    Gutiérrez-Ravé, V
    Torres-Tortosa, M
    Marín, J
    Valdayo, MJ
    Milla, M
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2003, 21 (10): : 543 - 551
  • [46] Immunological and Virological Responses to Highly Active Antiretroviral Therapy in HIV-1 Infected Children
    Ravinder Singh
    Aparna Mukherjee
    Mohit Singla
    Bimal Kumar Das
    Sushil Kumar Kabra
    Rakesh Lodha
    The Indian Journal of Pediatrics, 2017, 84 : 893 - 896
  • [47] Immunological and Virological Responses to Highly Active Antiretroviral Therapy in HIV-1 Infected Children
    Singh, Ravinder
    Mukherjee, Aparna
    Singla, Mohit
    Das, Bimal Kumar
    Kabra, Sushil Kumar
    Lodha, Rakesh
    INDIAN JOURNAL OF PEDIATRICS, 2017, 84 (12): : 893 - 896
  • [48] Virological and immunological correlates of HIV posttreatment control after temporal antiretroviral therapy during acute HIV infection
    van Paassen, Pien M.
    van Pul, Lisa
    van der Straten, Karlijn
    Buchholtz, Ninee V. J. E.
    Grobben, Marloes
    van Nuenen, Ad C.
    van Dort, Karel A.
    Boeser-Nunnink, Brigitte D.
    van den Essenburg, Mo D.
    Burger, Judith A.
    van Luin, Matthijs
    Jurriaans, Suzanne
    Sanders, Rogier W.
    Swelsen, Wendy T.
    Symons, Jori
    Klouwens, Michelle J.
    Nijhuis, Monique
    van Gils, Marit J.
    Prins, Jan M.
    de Bree, Godelieve J.
    Kootstra, Neeltje A.
    AIDS, 2023, 37 (15) : 2297 - 2304
  • [49] Virological, immunological response and safety of initial antiretroviral treatment in HIV late presenters in HIV Spanish National Cohort
    Bisbal, O.
    Rava, M.
    Dominguez-Dominguez, L.
    Jarrin, I.
    Iribarren, J.
    Gutierrez, F.
    Garcia Rosado, D.
    Gorgolas, M.
    Peraire, J.
    Poveda, E.
    Rubio, R.
    Moreno, S.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2020, 23 : 33 - 33
  • [50] HIV-1 Subtype and Virological Response to Antiretroviral Therapy: A Confirmatory Analysis
    Dolling, David I.
    Dunn, David T.
    Geretti, Anna-Maria
    Sabin, Caroline A.
    CLINICAL INFECTIOUS DISEASES, 2013, 56 (01) : 162 - U215